Table 4.
Comparison of peripheral innate and adaptive immune cells of COVID-19 adult patients with healthy adults.
| Variables | Adult (control) = 14 | Adult (case) = 29 | p -value | ||
|---|---|---|---|---|---|
|
Male = 7n (50%) |
Female = 7n (50%) |
Male = 17n (58.60%) |
Female = 12n (41.40%) |
||
| Median (IQR) | Mean ± SD | Median (IQR) | Mean ± SD | ||
| Age, years | 51.50 ± 9.53 | 58.93 ± 13.29 | Φ 0.069 | ||
| CD3+CD4+ T cell (%) | 56.93 ± 10.71 | 57.38 ± 12.15 | Φ 0.906 | ||
| CD3+CD8+ T cell (%) | 35.71 ± 9.63 | 34.24 ± 11.44 | Φ 0.680 | ||
| CD14+ monocyte (%) | 6.92 ± 2.38 | 5.10 ± 2.58 | Φ 0.032* | ||
| CD3+ Total T lymphocyte (%) | 71.00 (8) | 61.50 (21) | Ω 0.065 | ||
| CD4+/CD8+ ratio | 1.36 (0.86) | 1.26 (1.15) | Ω 0.371 | ||
| CD16+CD56+ Nk cell (%) | 5.50 (7) | 7.00 (10) | Ω 0.268 | ||
| CD19+ B cell (%) | 12.00 (5) | 11.00 (10) | Ω 0.155 | ||
Data are presented as median (IQR) and mean ± SD.
Ω, Mann–Whitney U; Φ, T-test. **p < 0.01.